Genetic evidence shows higher GLP-1 and lower GIP levels may have combined benefits for body weight and heart metabolism

Declaration of competing interest CSM reports grants through his institution from Merck, Massachusetts Life Sciences Center, Abbott, Amgen and Boehringer Ingelheim, he reports personal consulting fees and support through his institution from Ansh Inc., collaborative research support from LabCorp Inc., reports personal consulting fees from Nestle, Olympus, Genfit, Lumos, Novo Nordisk, Amgen, Corcept, Intercept, 89 Bio, Madrigal, Aligos, Esperion, Biodexa, Verdiva Bio, Boehringer Ingelheim, Abbott and Regeneron, reports educational activity meals through his institution or national conferences from Esperion, Merck, Boehringer Ingelheim and travel support and fees from UptoDate, TMIOA, Elsevier, MedScape and the Cardio Metabolic Health Conference and shares with Coherus Oncology. Neither CSM, as EIC, nor XL or SL were involved in decision making and/or handling this manuscript. All other authors declare no competing interest.